Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials.
Zhu X, Tian X, Yu C, Hong J, Fang J, Chen H.
Medicine (Baltimore). 2016 Aug;95(34):e4232. doi: 10.1097/MD.0000000000004232.
PMID:27559943
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease.
Morsy Y, Walberg Å, Wawrzyniak P, Hubeli B, Truscello L, Mamie C, Niechcial A, Gueguen E, Manzini R, Gottier C, Lang S, Scharl S, Blümel S, Biedermann L, Rogler G, Turina M, Ramser M, Petrowsky H, Arnold IC, Zeissig S, Zamboni N, Egli A, Niess JH, Hruz P, Knuth A, Fritsch R, Manz MG, Wawrzyniak M, Scharl M.
Gut Microbes. 2025 Dec;17(1):2530157. doi: 10.1080/19490976.2025.2530157. Epub 2025 Jul 20.
PMID:40685618
Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers.
Liao CK, Hsu YJ, Chern YJ, Yu YL, Lin YC, Hsieh PS, Chiang JM, You JF.